Format : 21 Videos + 21 Audios (.mp3) + 15 PDFs
Size: 5.72 GB
Release Year : 2025
Overview
The 9th Annual Update on Liver Disease is a comprehensive, advanced clinical program designed to provide healthcare professionals with the latest evidence-based developments in hepatology. This course delivers a focused review of modern approaches to diagnosing and managing complex liver diseases, with emphasis on emerging therapies, evolving clinical guidelines, and multidisciplinary care strategies.
Key areas of focus include metabolic dysfunction-associated steatohepatitis (MASH), alcohol-associated liver disease (ALD), autoimmune liver diseases, complications of cirrhosis, and hepatocellular carcinoma (HCC). The program is structured to support immediate application of knowledge into clinical practice.
Learning Objectives
Participants will be able to:
- Evaluate and implement updated management strategies for MASH, including weight loss interventions and GLP-1 receptor agonist therapies
- Apply advanced diagnostic and therapeutic approaches for autoimmune liver diseases, including autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), and primary biliary cholangitis (PBC)
- Assess and manage complications of cirrhosis, including ascites, spontaneous bacterial peritonitis (SBP), and portal vein thrombosis
- Integrate addiction medicine principles into hepatology care for patients with alcohol-associated liver disease
- Analyze current approaches to hepatocellular carcinoma surveillance and evaluate liver lesions using LI-RADS classification systems
Target Audience
This program is designed for healthcare professionals involved in the care of patients with liver and gastrointestinal diseases, including:
- Gastroenterologists and hepatologists
- GI surgeons
- Internal medicine and family practice physicians
- Nurse practitioners and physician assistants
- Other clinicians with an interest in hepatology and gastroenterology
Program Topics
Metabolic and Alcohol-Related Liver Disease
- Advances in MASH
- Updates in alcohol-associated liver disease (ALD): management and emerging therapies
- Integration of addiction medicine in hepatology practice
Autoimmune and Specialized Liver Conditions
- Autoimmune hepatitis (AIH): 2025 updates
- Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) case discussions
- Liver disease in pregnancy
Cirrhosis and Its Complications
- Management of ascites and SBP prophylaxis
- Portal vein thrombosis and anticoagulation strategies
- Malnutrition and frailty in cirrhosis patients
- Debate on primary prophylaxis of esophageal varices
Clinical Case Studies
- Hereditary hemochromatosis
- Drug-induced liver injury
- Metabolic dysfunction-associated steatotic liver disease (MASLD)
- Complex patient cases including portal hypertension and vascular disorders
Viral Hepatitis and Transplant Considerations
- Hepatitis B treatment and updated practice guidelines
- Referral criteria and considerations for liver transplantation evaluation
Oncology and Imaging
- Updates in hepatocellular carcinoma (HCC) surveillance
- Evaluation of liver lesions, including benign and indeterminate findings (LI-RADS classification)
Interactive Discussions
- Expert panel Q&A sessions on key clinical challenges
- Focused discussions on weight loss strategies, GLP-1 therapies, and lifestyle interventions in liver disease management
Key Benefits
- Evidence-based, clinically relevant content
- Practical insights for immediate implementation
- Exposure to current guidelines and emerging therapies
- Case-based learning and expert-led discussions
- Multidisciplinary approach to liver disease management
This program serves as an essential educational resource for clinicians seeking to stay current with the rapidly evolving field of hepatology while enhancing patient care outcomes.
